Sudarshan Chemical Industries Investor Presentation: Key Takeaways
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
Sudarshan Chemical Industries Ltd reported revenue from operations of ₹2,743 Cr (+14.9% YoY) and net profit of ₹30.5 Cr (+58.0% YoY) for Q2 FY27.
Sudarshan Chemical schedules a 6 November 2026 board meeting to consider unaudited quarterly and half-year results. Trading window stays closed until 8 November 2026.
Sudarshan Chemical completed sale of VP4 Frankfurt GmbH to Celanese for about Rs 795.9 crore. VP4 Frankfurt is no longer a step-down subsidiary.
Sudarshan Chemical allotted 19,350 equity shares to employees exercising options under its 2018 ESOP plan. The allotment is at an exercise price of Rs 349.35 per share.
India Ratings has revised the outlook on Sudarshan Chemical Industries' debt facilities to Positive from Stable, while affirming the existing credit ratings.
Sudarshan Chemical Industries submitted its quarterly shareholding pattern for the period ending 30 September 2026, consistent with regulatory filing requirements under Regulation 31.